{
  "docId": "019de073-8079-71bb-b12b-cbebf2163a3a",
  "docSlug": "9b4d00e952721e20753466aee3e72db7",
  "documentTitle": "BenevolentAI | Investor Day Presentation Deck | 74 slides",
  "authorId": "benevolentai",
  "authorName": "BenevolentAI",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 24,
  "pageCount": 74,
  "prevPage": 23,
  "nextPage": 25,
  "slideType": "key_takeaways",
  "function": "illustrate_case",
  "density": "overcrowded",
  "nDataPoints": 3,
  "notes": "The slide uses a split-layout with a dark-mode sidebar for AstraZeneca-specific details.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-8079-71bb-b12b-cbebf2163a3a/24",
  "deckHref": "/decks/019de073-8079-71bb-b12b-cbebf2163a3a",
  "deckJsonHref": "/decks/019de073-8079-71bb-b12b-cbebf2163a3a.json",
  "deckAnchorHref": "/decks/019de073-8079-71bb-b12b-cbebf2163a3a#slide-24",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.55,
        "y": 0.65
      },
      "kind": "callout",
      "text": "To date, three novel targets have been validated & selected for AstraZeneca’s portfolio",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c4d4f73c-0833-48eb-8962-e98f5a3c18b2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.2,
        "x": 0.55,
        "y": 0.78
      },
      "kind": "chart",
      "text": "CKD: Jan 2021; IPF: Dec 2021; IPF: May 2022",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6fcee212-8a73-4f10-bf71-e7dda4a4b7ad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.25,
        "x": 0.65,
        "y": 0.05
      },
      "kind": "image",
      "text": "AstraZeneca",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "607c4cc1-cc19-440a-a9b9-25fcaf8b634d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.45,
        "x": 0.05,
        "y": 0.45
      },
      "kind": "list",
      "text": "Separate data environment established to integrate AstraZeneca’s data into a bespoke Knowledge Graph; BenevolentAI and AstraZeneca teams working in close collaboration; Deal structure of upfront license fee, milestone payments and downstream royalties; Collaboration enables BenevolentAI to enrich its platform",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f0228f5c-d12f-425b-b5a9-6fd772d5edad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.4,
        "x": 0.55,
        "y": 0.18
      },
      "kind": "paragraph",
      "text": "THERAPEUTIC AREAS: INITIAL DEAL (APRIL 2019) Chronic kidney disease (CKD), Idiopathic pulmonary fibrosis (IPF); EXPANSION (DEC 2021) Heart failure, Systemic lupus erythematosus",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6d50cd38-0efa-4d36-8b9a-93c1f5502abf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.45,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "title",
      "text": "Multi-year Target-ID collaboration is delivering multiple, novel targets for complex diseases with high unmet need",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "84a1f054-080b-48b6-bd33-d87bb5deb093",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.45,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "Strategic validation: successful collaboration with AstraZeneca",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f861064d-ebfc-452f-969f-0e0f785983ef",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "list-presentation",
      "slug": null,
      "matchId": "4a4b1922-fd79-4e04-a821-10ee1057d5f9",
      "evidence": "Use of bullet points to summarize collaboration benefits",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 74,
      "from": 8,
      "beatId": "e075ee7a-56af-49ed-87dd-38efd7ca183a",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "The Benevolent Platform™: a versatile, scalable and proven AI-enabled R&D engine",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}